Swiss specialty chemicals company making catalysts, additives and care-chemical ingredients for industrial and consumer customers.
Swiss specialty chemicals company making catalysts, additives and care-chemical ingredients for industrial and consumer customers.
Sells specialty chemicals on repeat orders: catalysts that wear out and are replaced in refineries and chemical plants, and ingredients that consumer-goods makers specify into their formulas. It has sold off non-core businesses, including masterbatches and pigments, to focus on three units: care chemicals, catalysts, and adsorbents and additives.
In one line: A specialty chemicals maker like a smaller Ecolab/Albemarle hybrid.
Moat: narrow (process know-how, IP / patents, customer qualification). Specialized catalyst and formulation know-how creates embedded, hard-to-switch customer relationships in niche chemistries.
Headquarters: Muttenz, Switzerland · Founded: 1995 · Employees: 10,281
Size Clariant (CLN.SW) is a Switzerland Materials company (Chemicals: Specialty) with a market value of $4.20B, the 62nd largest of 155 Switzerland companies the cockpit tracks. Shares closed at CHF 10.75 on 18 Nov 2026.
Performance Over six months the shares gained 35.4%, against -25.8% for the median peer and +9.3% for the Switzerland market (cap-weighted) — highest of 20 in its peer set.
Growth Revenue fell 6.6% over the last twelve months (peer median +12.9%); the operating margin is 9.9% (peer median 13.8%).
Valuation It trades at 16.3× forward earnings against a peer median of 17.2× (11th cheapest of 21).
Price implies For today's price to make sense, revenue must grow about -3% a year for seven years (Req g). Recent delivered growth is 0%, so the hurdle is -4 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 2.9 points above its cost of capital (5.0% WACC).
Credit Clariant has 6 bonds outstanding ($1.44B), rated BBB- by the agencies and trading like BB+ at a weighted spread of 146 bp.
Next results Next results expected around 23 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CHF 3.79B | CHF 3.92B | CHF 4.15B | CHF 4.38B | CHF 5.20B |
| Revenue growth | — | -6% | -5% | -16% | — |
| Gross profit | CHF 1.18B | CHF 1.22B | CHF 1.29B | CHF 1.20B | CHF 1.49B |
| EBITDA | CHF 623M | CHF 650M | CHF 676M | CHF 719M | CHF 896M |
| Net income | -CHF 30.7M | -CHF 75.0M | CHF 244M | CHF 134M | CHF 84.0M |
| Free cash flow | CHF 302M | CHF 234M | CHF 184M | CHF 219M | CHF 264M |
| Capital expenditure | CHF 130M | CHF 146M | CHF 209M | CHF 207M | CHF 212M |
| Total debt | n/a | CHF 2.03B | CHF 1.88B | CHF 1.35B | CHF 1.46B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Clariant CLN.SW | $4.20B | +35% | -7% | 10% | 16.3× | -3.3% |
| Basf BAS.DE | $50.1B | 0% | -4% | 7% | 15.8× | 5.7% |
| Ecolab ECL | $84.3B | +21% | +9% | 18% | 33.6× | 20.3% |
| Croda International CRDA.L | $7.07B | +29% | +3% | 16% | 24.2× | 21.0% |
| Evonik Industries EVK.DE | $11.1B | +27% | +2% | 10% | 12.1× | -5.6% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | CLN.SW | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +3.8% | -4.3% | 2nd highest of 21 |
| 6-month return | +35.4% | -25.8% | highest of 20 |
| Distance from 52-week high | -3.7% | -43.8% | highest of 21 |
| Revenue growth (TTM) | -6.6% | +12.9% | 3rd lowest of 21 |
| Operating margin | 9.9% | 13.8% | 9th lowest of 21 |
| Forward P/E | 16.3× | 17.2× | 11th cheapest of 21 |
| Growth the price implies (Req g, 7 yrs) | -3.3% | 6.9% | 4th least demanding of 17 |
| Growth delivered (Del g) | +0.3% | +11.4% | 2nd lowest of 17 |
| Hurdle (Req g minus delivered) | -3.6 pp | -5.3 pp | 8th most demanding of 17 |
| ROIC minus cost of capital | +2.9 pp | +1.4 pp | 10th highest of 21 |
| EV / EBITDA | 8.3× | 7.1× | 4th most expensive of 8 |
| Net debt / EBITDA | 2.4× | 1.4× | 3rd most indebted of 8 |
| Bond spread | 146 bp | n/a | — |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Clariant CLN.SW | Switzerland | $4.20B | +35% | -7% | 10% | 16.3× | -3.3% | +0.3% |
| Zhejiang Sanmei Chemical Industry 603379.SS | China | $4.20B | -27% | +24% | 41% | 12.2× | 3.8% | +16.5% |
| Guangxi Huaxi Nonferrous Metal 600301.SS | China | $4.27B | -25% | +24% | 32% | 22.6× | 9.1% | +44.9% |
| GEM 002340.SZ | China | $4.12B | -35% | +2% | 7% | 14.6× | 3.5% | +24.4% |
| Air Water 4088.T | Japan | $4.34B | +34% | +11% | 3% | 11.8× | 9.4% | +6.8% |
| Far Eastern New Century 1402.TW | Taiwan | $4.39B | +2% | +5% | 7% | 11.5× | 4.7% | +4.2% |
| Dottikon ES DESN.SW | Switzerland | $4.63B | -26% | +11% | 27% | 38.2× | 13.4% | +14.4% |
| Cabot CBT | United States | $3.80B | -5% | +1% | 14% | 11.3× | -2.3% | +1.9% |
| Jiangsu Nata Opto-electronic Material 300346.SZ | China | $4.65B | -26% | +15% | 16% | 67.2× | 37.7% | +34.2% |
| Red Avenue New Materials 9607.HK | Hong Kong | $4.66B | n/a | +30% | 9% | 28.7× | n/a | n/a |
| Cathay Biotech 688065.SS | China | $3.77B | -23% | +9% | 18% | 34.3× | n/a | n/a |
| Mitsubishi Gas Chemical 4182.T | Japan | $3.76B | -32% | +9% | 9% | 10.2× | n/a | n/a |
| Bluestar Adisseo 600299.SS | China | $3.70B | -34% | +15% | 13% | 11.3× | -9.4% | +7.7% |
| Hangzhou Oxygen Plant 002430.SZ | China | $3.70B | -16% | +16% | 11% | 19.8× | 2.2% | +8.5% |
| Canmax Technologies 300390.SZ | China | $4.80B | -63% | +98% | 27% | 6.2× | n/a | n/a |
| IMEIK Technology Development 300896.SZ | China | $3.66B | -25% | -7% | 45% | 22.4× | 17.5% | +28.0% |
| Hoshine Silicon Industry 603260.SS | China | $4.85B | -35% | -7% | -6% | 39.6× | 21.1% | +18.5% |
| Do-Fluoride New Materials 002407.SZ | China | $3.62B | -42% | +69% | 7% | 33.9× | 17.3% | +17.5% |
| NOF 4403.T | Japan | $3.60B | -10% | +22% | 17% | 13.6× | -7.4% | +8.4% |
| Pangang Group Vanadium & Titanium Resources 000629.SZ | China | $3.60B | -26% | +6% | 4% | 57.3× | 26.1% | -3.4% |
| Methanex MX.TO | Canada | $4.93B | +10% | +31% | 23% | 6.8× | -9.5% | +7.1% |
Clariant has 6 bonds outstanding with $1.44B face value. The agencies rate it BBB-; its bonds trade like BB+. Weighted yield 2.91%, a spread of 146 bp over government bonds.